Stories about Health / Medicine

Subscribe to topic
Subscribe to Health / Medicine
Language:
english
Content:
All
Date:
All
Yesterday
Last 7 days
September
Reset
17.09.2018 – 16:00

Fresenius Kabi

Fresenius Kabi to Announce Winner of EUR 100,000* Research Grant to Support Parenteral Nutrition Research in Latin America at the FELANPE Congress in Mexico

Bad Homburg (ots) - Global healthcare company Fresenius Kabi will announce the winner of the first EUR 100,000* Parenteral Nutrition Research Grant Latin America at the FELANPE congress in Guadalajara, Mexico, from September 22-25. The announcement will be made during Fresenius Kabi's satellite symposium, in Salón ...
28.08.2018 – 12:31

Syntellix AG

Syntellix's acquisition of 73% stake in materials specialist MSE results in strategically important vertical integration ahead of intended international flotation

Hannover (ots) - At yesterday's AGM, shareholders of Syntellix AG approved all the management's proposed resolutions by an overwhelming majority of 99%. - Preparations for the intended IPO will be supported by a multinational Supervisory Board comprising internationally renowned personalities from the world of ...
27.06.2018 – 13:30

Digital Education Holdings

Novel EU study system EDU for human medicine approved

Valletta (ots) - Intensive practical training in high-end hospitals located in students home region accompanied by state-of-the-art online learning - admissions open for students in Germany today "The innovative EDU study model provides the best possible education in clinical medicine to young people with an intrinsic passion for becoming a physician. EDU is thus committed to help shape a fairer and ...
08.05.2018 – 09:00

Debiopharm International SA

FDA Grants Fast Track designation to Debiopharm International's Debio 1347 for the treatment of patients with unresectable or metastatic tumors with a specific FGFR gene alteration

Lausanne, Switzerland (ots) - Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Debio 1347, an FGFR 1-3 Inhibitor, for the ...
27.02.2018 – 11:00

Hitachi Medical Systems Europe Holding AG

Hitachi Medical Systems Europe announces "ScanSync" - a new function for diagnostic ultrasound that reduces the burden on operators - which is to be supported by the "ARIETTA Prologue"

Vienna (ots) - - Indication: Picture can be downloaded free of charge under: http://www.presseportal.ch/de/nr/100012989?langid=2 - This function enables the operation of the diagnostic ultrasound system via auto detection of transducer movement. Hitachi Medical Systems Europe, a wholly owned subsidiary of Hitachi, Ltd. (TSE: 6501, "Hitachi") today announced "Scan-Synced control" (hereafter ScanSync), a function that allows automatic ultrasound ...
15.02.2018 – 09:00

Debiopharm International SA

Debiopharm continues the fight against antibiotic resistance with investment in ABAC Therapeutics Inc. / ABAC develops new targeted antibiotics for patients with severe infections

Lausanne (ots) - Debiopharm Group (TM) announces an investment in antibiotic development with the acquisition of a minority stake in ABAC Therapeutics Inc. This investment was made through the Debiopharm Innovation Fund, its strategic investment fund, and illustrates the synergy between the group companies in the ...